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Background:Majority of the large cohort studies on heart failure involved Western
countries and developed nations. The ADHERE International Asia-Pacic study was
the only major cohort that included Asian nations, 7.1%of which, (out of a total pop-
ulation of 10,171) were from the Philippines. This research was done in conjunction
with a nationwide prevalence study on acute heart failure, which is the rst heart
failure study to be done encompassing the entire Philippine archipelago.
Purpose: To determine the predictors of mortality among hospitalized adult heart
failure patients in the Philippines
Methodology: The study is a nationwide retrospective cohort that involved all adult
patients aged 19 years old and above hospitalized for heart failure in 2014. Data
was collected from the hospitalization claims database of thePhilippine Health Insur-
ance Corporation (PhilHealth), a government corporation that administers the health
insurance program for the country. Univariate and multivariate analysis was done in
determining predictors of mortality
Results: A total of 44,046 hospitalized heart failure patients were included in the
study, with an in-hospital mortality rate of 8.2%.Multivariate analysis was done using
logistic regression which showed the following independent factors as predictors
of increased in-hospital mortality: government hospital admission (odds ratio (OR)
2.14, 95% condence interval (CI) 1.89 – 2.42), ward stay (OR 1.24, 95% CI 1.10 –
1.40), and regional classication to regions V (OR 1.42, 95% CI 1.07 – 1.87) and VII
(OR 1.31, 95% CI 1.05 – 1.62). Independent variables associated with in-hospital
survival are shorter length of hospital stay (OR 0.98, 95% CI 0.97 – 0.99), geograph-
ical classication under regions I (OR 0.72, 95% CI 0.58 - 0.89), II (OR 0.31, 95%
CI 0.20 - 0.49), IX (OR 0.74, 95% CI 0.58 - 0.96), Cordillera Autonomous Region
(CAR) (OR 0.59, 95% CI 0.44 - 0.78) and Autonomous Region of Muslim Mindanao
(ARMM) (OR 0.41, 95% CI 0.23 - 0.73) and having hypertension (OR 0.68, 95% CI
0.59 - 0.77) and cardiomyopathy (OR 0.17, 95% CI 0.06 - 0.47) as the etiology of
heart failure.
Conclusions: Heart failure patients in the Philippines are relatively younger com-
pared to patients in the Western and developed countries. Government hospital
admission, ward admission and residing in regions V and VII are the independent
predictors of mortality for hospitalized adult heart failure patients in the country. Liv-
ing in regions I, II, IX, CAR and ARMM and hypertension as the etiology of heart
failure independently predict in-hospital survival. Ward admission and hypertension
as the etiology of heart failure, as predictors of in-hospital mortality/survival, should
be further validated. Future studies on the outcomes of heart failure should include
more variables, clinical or non-clinical, to ascertain the most signicant predictors
of outcomes
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Introduction: It has been suggested that carriers of non-O blood groups (ABO
groups A, B, and AB) have higher cardiovascular (CV) risk, including risk for myocar-
dial infarction (MI), stroke, heart failure and CV death. However, this assumption
is mainly based on case-control studies, which showed a skewed blood group
distribution in subjects with CV events, but have a low level of evidence.
Methods:We performed a meta-analysis of prospective studies reporting on blood
group and CV events. We searched for terms "ABO blood group" and "myocardial
infarction, coronary artery disease, ischemic heart disease, heart failure, stroke,
cardiovascular events, cardiovascular mortality and all-cause mortality", and initially
retrieved 531 articles. After exclusion of studies with diseased subjects and studies
with inappropriate CV endpoints, 9 articles describing 11 prospective cohorts,
that reported on CV morbidity and mortality in both O and non-O blood groups,
remained.
Results: The total number of subjects included in all studies was 1,362,569, and
they experienced 23,154 CV events. The odds ratio’s (OR, with 95% Condence
Intervals, CI) for subjects having non-O blood groups compared to O blood group
for fatal coronary events, all coronary events and combined CV events were 1.00
(CI 0.85-1.18; p-value: 0.98), 1.09 (CI 1.06-1.13; p-value: 0.00001) and 1.09<
(CI 1.06-1.11; p-value: 0.006), respectively. Several sensitivity analyses did not
materially change the results.
Conclusion: Our meta-analysis shows that subjects carrying non-O blood group
have an increased risk of (nonfatal) CV events, especially myocardial infarction.
Underlying mechanisms may vary, although this increased risk has been attributed
to a higher concentration of von Willebrand factor and dyslipidemia in subjects with
non-O blood group. Further studies should address if the excess CV risk of non O
blood group is amenable to treatment.
Coronary events
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Background: Heart failure (HF) is a major health problem in developed coun-
tries, accounting for a signicant social and economic burden. Published
estimates of costs associated with HF patients in the primary care setting are
scarce.
Purpose: To determine the clinical and demographic characteristics of adult
patients with a HF diagnosis in a Portuguese primary care comprehen-
sive administrative database and to estimate the associated annual costs
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Methods:Population-based studywith real data covering a population of 3.6 million
patients attending primary care services in a large health region in Portugal. All
adult users coded for HF with at least one visit in 2014 were selected. We analyzed
patients’ characteristics, comorbidities (anemia, diabetes, hypertension, cere-
brovascular disease, atrial brillation, ischemic heart disease, cardiomyopathies,
valve disease, chronic obstructive pulmonary disease, pulmonary embolism, alco-
hol abuse), and resource use in 2014 related to medical tests and cardiovascular
diagnostic procedures, visits and cardiovascular or anticoagulant medication. Unit
costs estimates were based on national sources.
Results: We identied 25,337 patients, with an estimated HF prevalence of 1.4%.
This is approximately 30%of number expected according to a previously conducted
national community-based epidemiological survey. The differencemay be explained
by both underdiagnosis and underregistration. Patients with HF are mostly women
(58%) and on average 77±11 years old. The large majority of patients (93%) had
at least one of the selected comorbidities present, 70% had 2 or more and 38%
had 3 or more. About two thirds of patients (65%) had at least one medical test
or diagnostic procedure done during 2014. Blood tests, echocardiogram, elec-
trocardiogram and chest x-ray were performed in 61%, 16%, 14% and 11% of
patients, respectively. The majority of patients (56%) had at least four ofce visits
during one year. Angiotensin-converting enzyme inhibitor or angiotensin receptor
blockers, beta-blockers, and aldosterone blockers were prescribed for 80%, 48%
and 20% of patients, respectively. Only 12% of patients were prescribed all three
drug classes. The average annual cost per patient was estimated at €552 348,±
of which 54%, 40% and 6% was associated to medications, medical visits and
medical tests or diagnostic procedures, respectively.
Conclusions: This study provides a characterization of patients with HF in a large
population in a primary care setting. Surprisingly 70% of the expected number
of patients are either not diagnosed or not registered. HF patients are old, mostly
women and characterized by multimorbidity. The average annual cost per patient
was estimated to be about €550.
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Background: The age- and gender-specic risk of all-cause mortality for newly
diagnosed heart failure (HF) patients (pts) comparing with general population is
lacking. In Taiwan, the national health insurance (NHI) provides a population-based
data with longitudinal follow-up for assessing the issue.
Purpose: We evaluated the relative risk (RR) of all-cause mortality between newly
diagnosed HF pts and non-HF subjects.
Methods: The age- and gender-matched case-cohort study estimated the RR
of all-cause mortality in HF pts by using all insured data between 2002 and
2013. By excluding prevalent HF pts in 2002, incident and new HF cases should
have at least three outpatient visits or one hospital admission with HF (ICD9CM
code: 428, 402.01, 402.11, 402.91) between 2003 and 2012. The last insured
date was the surrogate endpoint of death. The data in 2013 was to sure those
withdrawn before 2012 for at least one year. Each HF pt had a control, randomly
sampled from the same age- and gender- subgroup. A total of 1,392,334 sub-
jects including 696,167 HF cases were analyzed. RR was estimated by Poisson
and negative-binomial regression models. We further used all-cause mortality
from the life table in the whole population to estimate the all-cause mortality
of HF.
Results: Two thirds of HF pts were diagnosed at 65 years (yrs) or older. Among HF
pts, the RR of all-cause mortality was higher in male (1.33, 95% CI=1.31-1.34), and
getting higher with aging (45-64 vs. <45 yrs: RR=1.4; >=65 vs 45-64 yrs: RR=5.2;
both p<0.05). When compared with non-HF subjects, the overall RR of all-cause
mortality for HF pts was 2.41 (95% CI:2.40-2.43). In both gender (Figure 1A), the
RRs of the younger groups were much higher. Although the age-specic RR for HF
pts with either gender were similar, the estimated all-cause mortality in male HF pts
was higher due to higher age-specic all-cause mortality in male population (Figure
1B).
Conclusions: When compared with non-HF controls, there remains a more than
two-fold risk of all-cause mortality for newly diagnosed HF pts. The mortality burden
was much greater on the elderly and male gender. The younger HF pts, however,
carry a rather high risk of death, when compared to the non-HF younger population.
All suggest the diverse but critical age- and gender-specic burdens of HF among
the whole population.
Figure 1A and 1B
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Background: The demographic change, i. e. an increase in elderly people in the
general population with an increase in comorbidities, is also reectedwithin the two
leading causes for hospitalization in Germany, which are "Delivery/Birth" (Z38) and
"Heart Failure" (I50). We analyzed data available from the German Federal Statistical
Ofce for both diagnoses from 2000 to 2015.
Methods: We used publically available databases for ICD-10-GM diagnoses in
Germany and compared the two most common reasons for hospitalization.
Results: Data were available from 2000 to 2015 for heart failure and from 2004
to 2015 for birth. Hospitalization for birth increased by 1.55 %/year from 444,306
(2004) to 526,437 (2015) [+82,131]. Hospitalization for heart failure increased by
4.96 %/year from 260,803 (2004) to 444,632 (2015) [+183,829] effecting heart
failure to become the most common cause for disease-related hospitalization in
Germany. Should these trends continue, there will be more hospitalizations for heart
failure than for birth from 2020 onwards.
Conclusion: The demographic change in Germany will lead to a greater need for
comprehensive heart failure care, while the number of hospitalizations for birth only
mildly increased at last. Some geographic areas might consider converting labour
rooms into comprehensive heart failure clinics.
Trends in Hospitalisation for Birth/HF
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